Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Managing the Business of Science

Managing the Business of Science Managing the Business of Science Walter F. Boron This editorial picks up on a theme introduced in my editorial from October 2006, titled “NIH Funding of the Independent Investigator” ( 1 ). Thus, like the previous one, this editorial deals with science policy and mainly pertains to the United States. I apologize for being somewhat provincial, but the issues may resonate with some readers outside the USA. I am concerned about two major and interrelated issues: 1 ) the money available to perform investigator-initiated research and 2 ) the management of resources at both universities and funding agencies such as the National Institutes of Health (NIH). When I received my first NIH grant in around 1981, the payline (i.e., the percentile at or below which funding is assured) was in the mid-30s, and every faculty member in the department had a grant. Moreover, the Dean of the Yale School of Medicine (Robert W. Berliner) provided my department chair (Emile L. Boulpaep) with a sufficiently large budget that Emile could set aside funds for the occasional renovation of laboratories and hiring of new faculty. As an aside, I might point out that the NIH’s funding of Big Science was http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Physiology The American Physiological Society

Managing the Business of Science

Boron, Walter F.
Physiology , Volume 24 (1): 2 – Feb 1, 2009
Download PDF
3 pages

Loading next page...
 
/lp/the-american-physiological-society/managing-the-business-of-science-WDnvyjX8s6

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
The American Physiological Society
Copyright
Copyright © 2011 the American Physiological Society
ISSN
1548-9213
eISSN
1548-9221
DOI
10.1152/physiol.00044.2008
pmid
19196646
Publisher site
See Article on Publisher Site

Abstract

Managing the Business of Science Walter F. Boron This editorial picks up on a theme introduced in my editorial from October 2006, titled “NIH Funding of the Independent Investigator” ( 1 ). Thus, like the previous one, this editorial deals with science policy and mainly pertains to the United States. I apologize for being somewhat provincial, but the issues may resonate with some readers outside the USA. I am concerned about two major and interrelated issues: 1 ) the money available to perform investigator-initiated research and 2 ) the management of resources at both universities and funding agencies such as the National Institutes of Health (NIH). When I received my first NIH grant in around 1981, the payline (i.e., the percentile at or below which funding is assured) was in the mid-30s, and every faculty member in the department had a grant. Moreover, the Dean of the Yale School of Medicine (Robert W. Berliner) provided my department chair (Emile L. Boulpaep) with a sufficiently large budget that Emile could set aside funds for the occasional renovation of laboratories and hiring of new faculty. As an aside, I might point out that the NIH’s funding of Big Science was

Journal

Physiology – The American Physiological Society

Published: Feb 1, 2009

There are no references for this article.